AHSG and metabolic dysfunction-associated steatotic liver disease: They appear to play opposing roles in the development of MASLD, with fetuin-A promoting insulin resistance and inflammation and consequently the development and progression of MASLD, whereas FGF21 appears to have protective effects by regulating lipid and glucose homeostasis and fatty acid oxidation [39].